ClinicalTrials.Veeva

Menu

Nutrition21 Study 1 (N21-1)

Texas A&M University logo

Texas A&M University

Status

Completed

Conditions

Nutritional Supplementation

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Arginine

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04828278
IRB2020-0181D

Details and patient eligibility

About

The purpose of this study is to determine the effects of nooLVL containing arginine and inositol supplementation on executive function and memory prior to and following playing video games.

Full description

Gaming or "E-Sports" has become a very popular activity particularly among younger individuals. It requires quick reactions, executive function, memory and fine motor skill. In E-Sport competitions and tournaments, E-Sport players often play for hours per session over a series of days. Thus, the ability to maintain cognitive and executive function, concentration and fine motor skill is paramount. Two recent studies have evaluated the effects of ingesting bonded arginine silicate (ASI) and ASI with additional inositol on cognitive function. In the first study, ASI supplementation (1,500 mg/d for 3 days and 14 days) significantly improved the ability to perform complex cognitive tests requiring mental flexibility, processing speed and executive functioning. In the second study, adding 100 mg of inositol to the ASI significantly improved cognitive function in gamers after playing video games for one hour. This study is designed to assess the effects of bonded arginine silicate and inositol ingestion on reaction time and cognitive function prior to and following a 1-hour gaming challenge.

Enrollment

24 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • They are a healthy male or female Gamer 18 to 40 years of age;
  • They have a Body Mass Index (BMI) between 18 and 34.9 kg/m2;
  • They are willing to supply their own operator-oriented action or stragegy video game that they have played 21 times over the last 3 months and the gaming platform with all accessories needed to play the chosen game;
  • They report no recent ingestion (<2 weeks) of dietary supplements that affect cognitive function including nitrates and nitrous oxide (NO2) promoting supplements;
  • They have a willingness to provide voluntary, written informed consent to participate in the study;

Exclusion criteria

  • They have known cardiovascular, metabolic and/or other diseases under the treatment of a physician requiring prescription (Rx) medication (birth control is allowed);
  • They have a history of cognitive dysfunction;
  • They have a known allergy to maltodextrin;
  • They have known allergies or asthma;
  • They have cirrhosis;
  • They have guanidinoacetate methyltransferase deficiency;
  • They have herpes;
  • They have abnormally low blood pressure;
  • They have had a recent heart attack (i.e., within one year);
  • They have kidney disease;
  • They have a surgery scheduled in the next 4-5 weeks;
  • Thye have had a gastrectomy;
  • They have a bipolar disorder;
  • They have an allergy to aspirin or tartrazine products;
  • They are pregnant or breast-feeding or plan to become pregnant in the next 4-5 weeks;

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

24 participants in 2 patient groups, including a placebo group

Treatment 1
Placebo Comparator group
Description:
1,600 mg of Placebo (maltodextrin)
Treatment:
Dietary Supplement: Placebo
Treatment 2
Active Comparator group
Description:
1,500 mg of ASI (bonded arginine silicate) + 100 mg of inositol (nooLVL)
Treatment:
Dietary Supplement: Arginine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems